NBD AI Bulletin -- Sichuan Kelun Pharmaceutical Co., Ltd (SZ 002422, close price: 21.28 yuan) March 1 said that the Company's controlling shareholder Liu Gexin on the day released about 2.31 million shares that were pledged to Huatai Securities.

The 2020 semiannual report shows that Sichuan Kelun Pharmaceutical's main business is the pharmaceutical manufacturing industry, accounting for 97.43% of revenue.

Sichuan Kelun Pharmaceutical's chairman is Liu Gexin, male, 70 years old, Chinese national, no overseas right of abode, master's degree, senior engineer. Sichuan Kelun Pharmaceutical's general Manager is Liu Sichuan, male, 37 years old, Chinese national, no overseas right of abode, master's degree.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.